EVALUATE THE EFFICACY OF LONG-COURSE NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS WITH STAGE II–III LOW RECTAL CANCER TREATED AT 108 MILITARY CENTRAL HOSPITAL. YHCĐ. 2026;67(CĐ7-Trường ĐH Y Dược Hải Phòng). doi:10.52163/yhc.v67iCD7.5614